Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

87 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Orphan Drug Designation and Exclusivity for "Same Drugs".
Hong P, Sarpatwari A, Kesselheim AS. Hong P, et al. Among authors: sarpatwari a. J Law Med Ethics. 2019 Jun;47(2):347-349. doi: 10.1177/1073110519857293. J Law Med Ethics. 2019. PMID: 31298092 No abstract available.
Using a drug-safety tool to prevent competition.
Sarpatwari A, Avorn J, Kesselheim AS. Sarpatwari A, et al. N Engl J Med. 2014 Apr 17;370(16):1476-8. doi: 10.1056/NEJMp1400488. N Engl J Med. 2014. PMID: 24738666 No abstract available.
Regulatory Solutions to the Problem of High Generic Drug Costs.
Luo J, Sarpatwari A, Kesselheim AS. Luo J, et al. Among authors: sarpatwari a. Open Forum Infect Dis. 2015 Nov 13;2(4):ofv179. doi: 10.1093/ofid/ofv179. eCollection 2015 Dec. Open Forum Infect Dis. 2015. PMID: 26693494 Free PMC article.
Navigating the Dermatological Drug Cost Curve.
Sarpatwari A, Kesselheim AS. Sarpatwari A, et al. JAMA. 2016 Jun 28;315(24):2724-5. doi: 10.1001/jama.2016.3851. JAMA. 2016. PMID: 27367767 No abstract available.
Strategies That Delay Market Entry of Generic Drugs.
Vokinger KN, Kesselheim AS, Avorn J, Sarpatwari A. Vokinger KN, et al. Among authors: sarpatwari a. JAMA Intern Med. 2017 Nov 1;177(11):1665-1669. doi: 10.1001/jamainternmed.2017.4650. JAMA Intern Med. 2017. PMID: 28975217
87 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page